Compare Humana Inc (HUM) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Snap Inc — how do they compare? Humana Inc trades at $404.09 (market cap $47.81B), while Snap Inc trades at $4.57 (market cap $7.67B). The key difference: Humana Inc is far larger — about 6.2× Snap Inc's market cap, and Humana Inc pays a 0.89% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| HUM | SNAP | |
|---|---|---|
Market Cap | $47.81B | $7.67B |
Sector | Health | Media |
52-Week High | $409.42 | $10.35 |
52-Week Low | $163.67 | $3.93 |
Enterprise Value | $56.85B | $9.05B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Snap Inc. (SNAP) trades at $4.585, up 1.33% on the day, amid a bearish technical signal and mixed fundamentals. Revenue grew to $5.93 billion in 2025, but the company posted a net loss of $460.49 million, with a negative net margin of -6.72%. Recent news highlights the launch of high-priced AR glasses, which sparked investor concerns and a stock decline. The stock faces resistance near $5, with analyst consensus price target at $5.75, suggesting modest upside potential from current levels.
The outlook remains cautious; while cost-cutting and AR innovation offer long-term growth avenues, persistent losses, competitive pressures, and high debt levels pose significant risks. Investor sentiment is divided, with analysts mostly neutral to bullish, but the stock's performance hinges on achieving profitability and successful monetization of new initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
